For more than 80 years, The Children's Hospital of Philadelphia has built a reputation as a pioneer in pediatric research. Vaccines, therapies, and other interventions developed and tested at Children's Hospital have saved the lives of many children throughout the world and improved the health of countless others.
And this legacy continues today.
The success of The Children's Hospital of Philadelphia Research Institute can be attributed to building upon the Hospital's past as well as planning for the changes and initiatives necessary to achieve preeminence. The continued growth of the Hospital's research program not only involves increasing the amount of research funding, constructing buildings and winning the war for talent, but also embracing the entrepreneurial spirit – the notion of “going first and being first” – that has sustained Children's Hospital for 150 years.
To that end, we continue to pioneer new therapies, integrate novel technologies, and tackle the toughest healthcare issues that face our patients and their families. And we maintain our role as a leader in harnessing the data derived from patient care to guide and drive laboratory and clinical investigation, an approach that has served as the foundation of the “bench to bedside” nature of our research program.
Research is, and will continue to be, a cornerstone of the Hospital's mission and perhaps the key element in our overall goal of improving pediatric health worldwide. At The Children's Hospital of Philadelphia Research Institute, we are embarking upon a new era of research that will change the direction and intensity of our efforts while enhancing the care for our patients and families.
Philip R. Johnson, MD
Director, The Children's Hospital of Philadelphia Research Institute
Chief Scientific Officer and Senior Vice President